TrialBMC cancer2013

Study design: two long-term observational studies of the biosimilar filgrastim Nivestim™ (Hospira filgrastim) in the treatment and prevention of chemotherapy-induced neutropenia.

Didier Kamioner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.